{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:36:01Z","timestamp":1793716561422,"version":"4.6.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.09.043","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:38:27Z","timestamp":1790955507000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyponatremia after Chimeric Antigen Receptor T Cell Therapy: Biomarker or Therapeutic Target?"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6536-6984","authenticated-orcid":false,"given":"Lawrence Cheng Kiat","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tertius Tansloan","family":"Tuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-4701","authenticated-orcid":false,"given":"Jing Yuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Wei Inng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.09.043_bib0001","article-title":"The association between hyponatremia and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy [e-pub ahead of print]","author":"Hayashino","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.043_bib0002","article-title":"Frontal intermittent rhythmic delta activity is a useful diagnostic tool of neurotoxicity after CAR T-cell infusion","volume":"10","author":"Huby","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.043_bib0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5414\/CN109872","article-title":"Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells","volume":"93","author":"Dixon","year":"2020","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.043_bib0004","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"10 Suppl 1","key":"10.1016\/j.jtct.2026.09.043_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.043_bib0006","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"35","key":"10.1016\/j.jtct.2026.09.043_bib0007","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.21.01992","article-title":"Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline","volume":"39","author":"Santomasso","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.043_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.2022.11176","article-title":"Diagnosis and management of hyponatremia: a review","volume":"328","author":"Adrogu\u00e9","year":"2022","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.jtct.2026.09.043_bib0009","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJM198606123142402","article-title":"Osmotic demyelination syndrome following correction of hyponatremia","volume":"314","author":"Sterns","year":"1986","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.043_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2215\/CJN.0000000000000244","article-title":"Treatment guidelines for hyponatremia: stay the course","volume":"19","author":"Sterns","year":"2024","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:53:29Z","timestamp":1793714009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726007748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"alternative-id":["S2666636726007748"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.043","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatremia after Chimeric Antigen Receptor T Cell Therapy: Biomarker or Therapeutic Target?","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}